Loomis, Sayles & Company’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-180,901
Closed -$14.2M 869
2017
Q4
$14.2M Sell
180,901
-33,636
-16% -$2.71M 0.03% 357
2017
Q3
$18M Sell
214,537
-3,767
-2% -$267K 0.04% 307
2017
Q2
$14.3M Sell
218,304
-9,987
-4% -$679K 0.03% 332
2017
Q1
$16.6M Buy
228,291
+44,242
+24% +$2.91M 0.04% 308
2016
Q4
$10.8M Buy
+184,049
New +$9.72M 0.03% 417

Other funds holding ADNT

Loomis, Sayles & Company's ADNT Position: Q1 2018 in Review

Loomis, Sayles & Company sold out of Adient (ADNT) in Q1 2018, closing a stake of 180,901 shares — an estimated $14.2M sold.

Loomis, Sayles & Company first reported a position in ADNT in Q4 2016 and held it in 5 quarters. The position peaked at $18M in Q3 2017. 401 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

  • Loomis, Sayles & Company reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 180,901 Adient shares in Q1 2018, an estimated $14.2M.
  • Loomis, Sayles & Company first reported a position in Adient in Q4 2016 and held it in 5 quarters.
  • Loomis, Sayles & Company's Adient position peaked at $18M in Q3 2017.
  • 401 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.